Axsome Therapeutics (AXSM) Total Debt (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.97% |
| Dec 31, 2025 | 0.33% |
| Sep 30, 2025 | -32.10% |
| Jun 30, 2025 | -1.28% |
| Mar 31, 2025 | 5.13% |
| Dec 31, 2024 | -3.95% |
| Sep 30, 2024 | 0.95% |
| Jun 30, 2024 | 0.70% |
| Mar 31, 2024 | 0.33% |
| Dec 31, 2023 | 0.19% |
| Sep 30, 2023 | 0.52% |
| Jun 30, 2023 | 19.23% |
| Mar 31, 2023 | 53.37% |
| Dec 31, 2022 | -0.75% |
| Sep 30, 2022 | 1.51% |
| Jun 30, 2022 | 101.59% |
| Mar 31, 2022 | 0.45% |
| Dec 31, 2021 | -0.17% |
| Sep 30, 2021 | 0.60% |
| Jun 30, 2021 | 0.59% |
| Mar 31, 2021 | 0.57% |
| Dec 31, 2020 | 0.62% |
| Sep 30, 2020 | 136.68% |
| Jun 30, 2020 | 0.89% |
| Mar 31, 2020 | 0.89% |
| Dec 31, 2019 | 0.90% |
| Sep 30, 2019 | 0.90% |
| Jun 30, 2019 | 1.17% |
| Mar 31, 2019 | 180.04% |
| Dec 31, 2018 | -10.55% |
| Sep 30, 2018 | -8.79% |
| Jun 30, 2018 | -8.00% |
| Mar 31, 2018 | -7.30% |
| Dec 31, 2017 | -1.59% |
| Sep 30, 2017 | 1.20% |
| Jun 30, 2017 | 1.19% |
| Mar 31, 2017 | 1.19% |